Michael Martin

Biochemistry, Genetics and Molecular Biology · Life Sciences

30h-index5.1kcitations72works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PI3K/AKT/mTOR signaling in cancer(13), Retinal Diseases and Treatments(6), Chronic Myeloid Leukemia Treatments(6), Bone health and treatments(5), Cancer Treatment and Pharmacology(5)

Publications71 total

Abstract LB428: An orally bioavailable RIPTAC™ therapeutic for p53 Y220C mutant tumors
Cancer Research·2025
Rapid Assessment of Coagulation at the Point of Care With the Hemochron Signature Elite System
Point of Care The Journal of Near-Patient Testing & Technology·2020· 6 citedOpen Access
Implementation of Novel Protocols in an Ophthalmic Ambulatory Surgical Center to Resume Surgical Procedures During COVID-19
Quality Management in Health Care·2020· 3 cited
Abstract P6-18-16: Ribociclib (RIBO) + letrozole (LET) in older patients with hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC): Preliminary subgroup results from the phase 3b CompLEEment-1 trial
Cancer Research·2019
ANN based Data Mining Analysis of the Parkinson’s Disease
International Journal of Computer Applications·2017· 6 citedOpen Access
Abstract OT2-01-02: Phase III study of ribociclib (LEE011) in combination with fulvestrant for the treatment of postmenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (aBC) who have received no or only one line of prior endocrine treatment: MONALEESA-3
Cancer Research·2016· 3 cited
First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes—Chapter 2a: source pigs—preventing xenozoonoses
Xenotransplantation·2016· 48 cited
Angiographic Anatomy of External Iliac Arteries in the Sheep
Anatomia Histologia Embryologia·2015· 10 cited
Impact of donor age and weaning status on pancreatic exocrine and endocrine tissue maturation in pigs
Xenotransplantation·2015· 11 citedOpen Access
Erratum to: The influence of a CYP1A2 polymorphism on the ergogenic effects of caffeine
Journal of the International Society of Sports Nutrition·2015· 3 citedOpen Access
The Safety and Efficacy of Topical Retapamulin Ointment Versus Placebo Ointment in the Treatment of Secondarily Infected Traumatic Lesions
Advances in Skin & Wound Care·2013· 8 cited
Selective Inhibition of Phosphoinositide 3-Kinase p110α Preserves Lymphocyte Function*
Journal of Biological Chemistry·2012· 63 citedOpen Access
Abstract P6-07-06: Patterns of locoregional failure in the CALOR (Chemotheraphy as Adjuvant for Locally Recurrent Breast Cancer) Trial
Cancer Research·2012· 1 cited
605 A Phase 1, Open-label, Dose-escalation Study of Oral Administration of the Investigational Agent MLN0128 in Combination with Paclitaxel (P) in Patients (pts) with Advanced Solid Malignancies
European Journal of Cancer·2012· 3 cited
Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia
Leukemia·2012· 106 cited
The Effect of Caffeine on Performance in Collegiate Tennis Players
Journal of Caffeine Research·2012· 35 cited
Abstract CT-02: A phase I, open label, dose escalation study of oral mammalian target of rapamycin inhibitor INK128 administered by intermittent dosing regimens in patients with advanced malignancies
Cancer Research·2012· 16 cited
Abstract 2745: INK128, a TORC1/2 kinase inhibitor, enhances the efficacy of cytotoxic therapies in endometrial tumor models
Cancer Research·2012
Abstract 5588: A phase I, open label, dose escalation study of an oral mammalian target of rapamycin inhibitor INK128 administered once daily in patients with advanced malignancies
Cancer Research·2012· 82 cited
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Nature·2012· 1.3k citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Richard Söll(11), Glenn Noronha(10), John Doukas(9), John Hood(9), Eric Oldfield(9), Christian Rommel(8), Pingda Ren(6), Matthew R. Janes(5), Katti Jessen(5), Chi Ching Mak(5), Roberto Docampo(5), Shiyin Yee(5), Roberta Buono(4), Brian N. Bailey(4), Lian‐Sheng Li(4), Shunyou Wang(3), Ross L. Levine(3), Ayalew Tefferi(3), Julio A. Urbina(3), Luis Dellamary(3)